BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7989951)

  • 1. Salvage surgery for chemorefractory gestational trophoblastic disease.
    Lehman E; Gershenson DM; Burke TW; Levenback C; Silva EG; Morris M
    J Clin Oncol; 1994 Dec; 12(12):2737-42. PubMed ID: 7989951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease.
    Soper JT; Evans AC; Rodriguez G; Berchuck A; Clarke-Pearson DL; Hammond CB
    Gynecol Oncol; 1995 Mar; 56(3):421-4. PubMed ID: 7705678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of surgery in gestational trophoblastic disease.
    Bolis G; Belloni C; Vergadoro F; Colombo N; Buratti E; Mangioni C
    Tumori; 1983 Dec; 69(6):553-7. PubMed ID: 6320512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center.
    Mutch DG; Soper JT; Babcock CJ; Clarke-Pearson DL; Hammond CB
    Cancer; 1990 Sep; 66(5):978-82. PubMed ID: 2167150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
    Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein M
    J Reprod Med; 1989 Mar; 34(3):189-92. PubMed ID: 2470902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of surgical interventions in the treatment of patients with trophoblastic tumor resistant to chemotherapy].
    Meshcheriakova LA; Kozachenko VP
    Vopr Onkol; 1998; 44(5):610-4. PubMed ID: 9884727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm].
    Feng FZ; Xiang Y; Cao Y; Li L; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):728-31. PubMed ID: 19087536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gestational trophoblastic tumors--a report of experiences].
    Ebeling K; Schönborn I; Johannsmeyer D
    Zentralbl Gynakol; 1995; 117(5):237-42. PubMed ID: 7540787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.
    Clark RM; Nevadunsky NS; Ghosh S; Goldstein DP; Berkowitz RS
    J Reprod Med; 2010; 55(5-6):194-8. PubMed ID: 20626174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.
    Feng F; Xiang Y; Li L; Wan X; Yang X
    Gynecol Oncol; 2009 Jun; 113(3):312-5. PubMed ID: 19345988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study.
    Schmid P; Nagai Y; Agarwal R; Hancock B; Savage PM; Sebire NJ; Lindsay I; Wells M; Fisher RA; Short D; Newlands ES; Wischnewsky MB; Seckl MJ
    Lancet; 2009 Jul; 374(9683):48-55. PubMed ID: 19552948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical salvage of chemorefractory germ cell tumors.
    Murphy BR; Breeden ES; Donohue JP; Messemer J; Walsh W; Roth BJ; Einhorn LH
    J Clin Oncol; 1993 Feb; 11(2):324-9. PubMed ID: 8381163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmetastatic gestational trophoblastic disease.
    Soper JT; Hammond CB
    Obstet Gynecol Clin North Am; 1988 Sep; 15(3):505-19. PubMed ID: 2852331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J; Yang W; Wu X
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of emergency surgery in gestational trophoblastic tumours].
    Xiang Y; Yang X; Zhang L; Song H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Oct; 19(5):369-72. PubMed ID: 10453523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.